Publications searcher The science produced by our scientists is very important. In 2022, 1,629 papers were published in scientific journals with a global impact factor of over 15,000 points. Fulltext search Alphabetic A-Z Alphabetic Z-A A phase II trial of weekly nab-paclitaxel for progressive and symptomatic desmoid tumors. PMID: 36271011 Journal: Nature Communications Year: 2022 Reference: Nat Commun. 2022 Oct 21;13(1):6278. doi: 10.1038/s41467-022-33975-6. Impact factor: Publication type: Paper in international publication Authors: Arribas, Ivan; Di Lernia, Davide; Diaz-Beveridge, Roberto; Gutierrez, Antonio; Hindi, Nadia; Ledesma, Patricio; Lopez-Martin, Jose Antonio; Lopez-Pousa, Antonio; Luna, Pablo; Marcilla, David et al. DOI: 10.1038/s41467-022-33975-6 A Phase III, randomized, open-label study (CONTACT-02) of cabozantinib plus atezolizumab versus second novel hormone therapy in patients with metastatic castration-resistant prostate cancer. PMID: 35034502 Journal: Future Oncology Year: 2022 Reference: Future Oncol. 2022 Mar;18(10):1185-1198. doi: 10.2217/fon-2021-1096. Epub 2022 Jan 17. Impact factor: 3.404 Publication type: Paper in international publication Authors: McGregor, Bradley, Agarwal, Neeraj, Azad, Arun, Carles, Joan, Chowdhury, Simon, Saad, Fred, Soares, Andrey, Benzaghou, Fawzi, Kerloeguen, Yannick, Kimura, Akiko et al. DOI: 10.2217/fon-2021-1096 A Phase III, randomized, open-label study (CONTACT-02) of cabozantinib plus atezolizumab versus second novel hormone therapy in patients with metastatic castration-resistant prostate cancer. PMID: 35034502 Journal: Future Oncology Year: 2022 Reference: Future Oncol. 2022 Mar;18(10):1185-1198. doi: 10.2217/fon-2021-1096. Epub 2022 Jan 17. Impact factor: Publication type: Paper in international publication Authors: Agarwal, Neeraj; Azad, Arun; Benzaghou, Fawzi; Carles, Joan; Chowdhury, Simon; Kerloeguen, Yannick; Kimura, Akiko; McGregor, Bradley; Merseburger, Axel S; Mohamed, Nehal et al. DOI: 10.2217/fon-2021-1096 A phase-II study of atezolizumab in combination with obinutuzumab or rituximab for relapsed or refractory mantle cell or marginal zone lymphoma or Waldenstrom's macroglobulinemia. PMID: 35045765 Journal: LEUKEMIA & LYMPHOMA Year: 2022 Reference: Leuk Lymphoma. 2022 May;63(5):1058-1069. doi: 10.1080/10428194.2021.2015765. Epub 2022 Jan 19. Impact factor: 3.28 Publication type: Paper in international publication Authors: Willis, Jenna C, Buske, Christian, Perretti, Thomas, Katz, Pablo, Hamidi, Habib, Bottos, Alessia, Panayiotidis, Panayiotis, Tumyan, Gayane, Thieblemont, Catherine, Ptushkin, Vadim V et al. DOI: 10.1080/10428194.2021.2015765 A phase-II study of atezolizumab in combination with obinutuzumab or rituximab for relapsed or refractory mantle cell or marginal zone lymphoma or Waldenstrom's macroglobulinemia. PMID: 35045765 Journal: LEUKEMIA & LYMPHOMA Year: 2022 Reference: Leuk Lymphoma. 2022 May;63(5):1058-1069. doi: 10.1080/10428194.2021.2015765. Epub 2022 Jan 19. Impact factor: Publication type: Paper in international publication Authors: Bottos, Alessia; Buske, Christian; Garcia-Sanz, Ramon; Hamidi, Habib; Katz, Pablo; Le Gouill, Steven; Marin-Niebla, Ana; Panayiotidis, Panayiotis; Perretti, Thomas; Ptushkin, Vadim V et al. DOI: 10.1080/10428194.2021.2015765 A pilot study of circulating levels of TGF-beta1 and TGF-beta2 as biomarkers of bone healing in patients with non-hypertrophic pseudoarthrosis of long bones. PMID: 34950754 Journal: Bone reports Year: 2022 Reference: Bone Rep. 2021 Dec 9;16:101157. doi: 10.1016/j.bonr.2021.101157. eCollection 2022 Jun. Impact factor: 0 Publication type: Paper in international publication Authors: Chaverri, Daniel; Vivas, Daniel; Gallardo-Villares, Santiago; Granell-Escobar, Fernando; Pinto, Javier A; Vives, Joaquim et al. DOI: 10.1016/j.bonr.2021.101157 A pilot study of circulating levels of TGF-beta1 and TGF-beta2 as biomarkers of bone healing in patients with non-hypertrophic pseudoarthrosis of long bones. PMID: 34950754 Journal: Bone reports Year: 2022 Reference: Bone Rep. 2021 Dec 9;16:101157. doi: 10.1016/j.bonr.2021.101157. eCollection 2022 Jun. Impact factor: Publication type: Paper in international publication Authors: Chaverri, Daniel; Gallardo-Villares, Santiago; Granell-Escobar, Fernando; Pinto, Javier A; Vivas, Daniel; Vives, Joaquim et al. DOI: 10.1016/j.bonr.2021.101157 A Polygenic Risk Score Based on a Cardioembolic Stroke Multitrait Analysis Improves a Clinical Prediction Model for This Stroke Subtype. PMID: 35872910 Journal: Frontiers in Cardiovascular Medicine Year: 2022 Reference: Front Cardiovasc Med. 2022 Jul 8;9:940696. doi: 10.3389/fcvm.2022.940696. eCollection 2022. Impact factor: Publication type: Paper in international publication Authors: Alvarez-Sabin, Jose; Arenillas, Juan Francisco; Blay, Natalia; Campos, Francisco; Camps-Renom, Pol; Carcel-Marquez, Jara; Castillo, Jose; Cruchaga, Carlos; Cullell, Natalia; de Cid, Rafael et al. DOI: 10.3389/fcvm.2022.940696 A Pooled Analysis of Mortality in Patients with COPD Receiving Dual Bronchodilation with and without Additional Inhaled Corticosteroid. PMID: 35309285 Journal: International Journal of Chronic Obstructive Pulmonary Disease Year: 2022 Reference: Int J Chron Obstruct Pulmon Dis. 2022 Mar 11;17:545-558. doi: 10.2147/COPD.S350167. eCollection 2022. Impact factor: 3.355 Publication type: Paper in international publication Authors: Miravitlles, Marc, Verhamme, Katia, Calverley, Peter M A, Dreher, Michael, de la Hoz, Alberto, Wedzicha, Jadwiga, Price, David, Gardev, Asparuh, Bayer, Valentina et al. DOI: 10.2147/COPD.S350167 A Pooled Analysis of Mortality in Patients with COPD Receiving Dual Bronchodilation with and without Additional Inhaled Corticosteroid. PMID: 35309285 Journal: International Journal of Chronic Obstructive Pulmonary Disease Year: 2022 Reference: Int J Chron Obstruct Pulmon Dis. 2022 Mar 11;17:545-558. doi: 10.2147/COPD.S350167. eCollection 2022. Impact factor: Publication type: Paper in international publication Authors: Bayer, Valentina; Calverley, Peter M A; de la Hoz, Alberto; Dreher, Michael; Gardev, Asparuh; Miravitlles, Marc; Price, David; Verhamme, Katia; Wedzicha, Jadwiga et al. DOI: 10.2147/COPD.S350167 A pragmatic randomized trial evaluating pre-operative aqueous antiseptic skin solutions in open fractures (Aqueous-PREP): statistical analysis plan. PMID: 36096826 Journal: Trials Year: 2022 Reference: Trials. 2022 Sep 12;23(1):772. doi: 10.1186/s13063-022-06541-0. Impact factor: Publication type: Paper in international publication Authors: Abbott, Harper; Acerboni-Flores, Francesc; Achor, Timothy S; Adams, John D; Ahn, James S; Al-Asiri, Jamal; Alavedra-Massana, Anna; Alnasser, Ahmad; Altman, Kyle M; Amirhekmat, Arya et al. DOI: 10.1186/s13063-022-06541-0 A Preclinical and Phase Ib Study of Palbociclib plus Nab-Paclitaxel in Patients with Metastatic Adenocarcinoma of the Pancreas. PMID: 36970055 Journal: Cancer research communications Year: 2022 Reference: Cancer Res Commun. 2022 Nov 2;2(11):1326-1333. doi: 10.1158/2767-9764.CRC-22-0072. eCollection 2022 Nov. Impact factor: Publication type: Paper in international publication Authors: Borazanci, Erkut; Garcia-Carbonero, Rocio; Garrido-Laguna, Ignacio; Grossman, Joseph E; Hidalgo, Manuel; Huang, Xin; Kern, Kenneth; Laheru, Daniel; Lim, Kian-Huat; Lowy, Andrew M et al. DOI: 10.1158/2767-9764.CRC-22-0072 A Prospective, Multicenter Study of Closed System Extracorporeal Photopheresis for Children With Steroid-Refractory Acute Graft-Versus-Host Disease. PMID: 35124293 Journal: Transplantation and cellular therapy Year: 2022 Reference: Transplant Cell Ther. 2022 May;28(5):261.e1-261.e7. doi: 10.1016/j.jtct.2022.01.025. Epub 2022 Feb 4. Impact factor: 0 Publication type: Paper in international publication Authors: Kitko, Carrie L; Abdel-Azim, Hisham; Carpenter, Paul A; Dalle, Jean-Hugues; Diaz-de-Heredia, Cristina; Gaspari, Stefania; Gennery, Andrew R; Handgretinger, Rupert; Lawitschka, Anita et al. DOI: 10.1016/j.jtct.2022.01.025 A Prospective, Multicenter Study of Closed System Extracorporeal Photopheresis for Children With Steroid-Refractory Acute Graft-Versus-Host Disease. PMID: 35124293 Journal: Transplantation and Cellular Therapy Year: 2022 Reference: Transplant Cell Ther. 2022 May;28(5):261.e1-261.e7. doi: 10.1016/j.jtct.2022.01.025. Epub 2022 Feb 4. Impact factor: Publication type: Paper in international publication Authors: Abdel-Azim, Hisham; Carpenter, Paul A; Dalle, Jean-Hugues; Diaz-de-Heredia, Cristina; Gaspari, Stefania; Gennery, Andrew R; Handgretinger, Rupert; Kitko, Carrie L; Lawitschka, Anita et al. DOI: 10.1016/j.jtct.2022.01.025 A Prospective, Real-World, Multinational Study of Naloxegol for Patients with Cancer Pain Diagnosed with Opioid-Induced Constipation-The NACASY Study. PMID: 35267436 Journal: Cancers Year: 2022 Reference: Cancers (Basel). 2022 Feb 23;14(5). pii: cancers14051128. doi: 10.3390/cancers14051128. Impact factor: 6.639 Publication type: Paper in international publication Authors: Davies, Andrew, Cinieri, Saverio, Dupoiron, Denis, Espana Fernandez, Sofia, Leclerc, Johan, Montesarchio, Vincenzo, Mystakidou, Kyriaki, Serna, Judith, Tack, Jan, On Behalf Of The Nacasy Study Group et al. DOI: 10.3390/cancers14051128 A Prospective, Real-World, Multinational Study of Naloxegol for Patients with Cancer Pain Diagnosed with Opioid-Induced Constipation-The NACASY Study. PMID: 35267436 Journal: Cancers Year: 2022 Reference: Cancers (Basel). 2022 Feb 23;14(5). pii: cancers14051128. doi: 10.3390/cancers14051128. Impact factor: Publication type: Paper in international publication Authors: Cinieri, Saverio; Davies, Andrew; Dupoiron, Denis; Espana Fernandez, Sofia; Leclerc, Johan; Montesarchio, Vincenzo; Mystakidou, Kyriaki; On Behalf Of The Nacasy Study Group; Serna, Judith; Tack, Jan et al. DOI: 10.3390/cancers14051128 A Randomised Controlled Trial to Assess the Benefit of Posterior Rhabdosphincter Reconstruction in Early Urinary Continence Recovery after Robot-assisted Radical Prostatectomy. PMID: 33653674 Journal: European Urology Oncology Year: 2022 Reference: Eur Urol Oncol. 2022 Aug;5(4):460-463. doi: 10.1016/j.euo.2021.02.005. Epub 2021 Feb 27. Impact factor: Publication type: Paper in international publication Authors: Celma, Anna; Morote, Juan; Planas, Jacques; Regis, Lucas; Salazar, Aina; Santamaria, Anna; Trilla, Enrique et al. DOI: 10.1016/j.euo.2021.02.005 A randomised phase 2 study comparing different dose approaches of induction treatment of regorafenib in previously treated metastatic colorectal cancer patients (REARRANGE trial). PMID: 36335783 Journal: EUROPEAN JOURNAL OF CANCER Year: 2022 Reference: Eur J Cancer. 2022 Dec;177:154-163. doi: 10.1016/j.ejca.2022.09.037. Epub 2022 Oct 14. Impact factor: Publication type: Paper in international publication Authors: Aranda, E; Aranda, Enrique; Argiles; Argiles, Guillem; Argiles, Guillem; Argiles, Guillem; Benavides, M; Benavides, Manuel; Bennouna, J; Bennouna, Jaafar et al. DOI: 10.1016/j.ejca.2022.09.037 A randomized controlled trial of liposomal cyclosporine A for inhalation in the prevention of bronchiolitis obliterans syndrome following lung transplantation. PMID: 34587371 Journal: AMERICAN JOURNAL OF TRANSPLANTATION Year: 2022 Reference: Am J Transplant. 2022 Jan;22(1):222-229. doi: 10.1111/ajt.16858. Epub 2021 Oct 18. Impact factor: 8.086 Publication type: Paper in international publication Authors: Knoop, Christiane; Jaksch, Peter; Parmar, Jasvir; Ussetti, Piedad; Sole, Amparo; Muller-Quernheim, Joachim; Kessler, Romain; Wirtz, Hubert; Boerner, Gerhard; Denk, Oliver et al. DOI: 10.1111/ajt.16858 A randomized controlled trial of liposomal cyclosporine A for inhalation in the prevention of bronchiolitis obliterans syndrome following lung transplantation. PMID: 34587371 Journal: AMERICAN JOURNAL OF TRANSPLANTATION Year: 2022 Reference: Am J Transplant. 2022 Jan;22(1):222-229. doi: 10.1111/ajt.16858. Epub 2021 Oct 18. Impact factor: Publication type: Paper in international publication Authors: Behr, Juergen; Boerner, Gerhard; Denk, Oliver; Ghiani, Alessandro; Jaksch, Peter; Kessler, Romain; Kneidinger, Nikolaus; Knoop, Christiane; Monforte, Victor; Muller-Quernheim, Joachim et al. DOI: 10.1111/ajt.16858 A Randomized, Double-Blind Noninferiority Study to Evaluate the Efficacy of the Cabozantinib Tablet at 60 mg per Day Compared with the Cabozantinib Capsule at 140 mg per Day in Patients With Progressive, Metastatic Medullary Thyroid Cancer. PMID: 35403447 Journal: THYROID Year: 2022 Reference: Thyroid. 2022 May;32(5):515-524. doi: 10.1089/thy.2022.0027. Impact factor: 6.568 Publication type: Paper in international publication Authors: Badiu, Corin, Robinson, Bruce, Hughes, Brett G M, Keam, Bhumsuk, Parnis, Francis, Elisei, Rossella, Gajate, Pablo, Gan, Hui K, Kapiteijn, Ellen, Locati, Laura et al. DOI: 10.1089/thy.2022.0027 A Randomized, Double-Blind Noninferiority Study to Evaluate the Efficacy of the Cabozantinib Tablet at 60 mg per Day Compared with the Cabozantinib Capsule at 140 mg per Day in Patients With Progressive, Metastatic Medullary Thyroid Cancer. PMID: 35403447 Journal: THYROID Year: 2022 Reference: Thyroid. 2022 May;32(5):515-524. doi: 10.1089/thy.2022.0027. Impact factor: Publication type: Paper in international publication Authors: Badiu, Corin; Capdevila, Jaume; Elisei, Rossella; Faoro, Leonardo; Gajate, Pablo; Gan, Hui K; Hughes, Brett G M; Isaev, Pavel; Jarzab, Barbara; Kapiteijn, Ellen et al. DOI: 10.1089/thy.2022.0027 A randomized phase II study comparing consolidation with a single dose of (90)Y ibritumomab tiuxetan vs. maintenance with rituximab for two years in patients with newly diagnosed follicular lymphoma responding to R-CHOP. Long-term follow-up results. PMID: 34459702 Journal: LEUKEMIA & LYMPHOMA Year: 2022 Reference: Leuk Lymphoma. 2022 Jan;63(1):93-100. doi: 10.1080/10428194.2021.1971216. Epub 2021 Aug 30. Impact factor: 3.28 Publication type: Paper in international publication Authors: Canales, Miguel Angel; Lopez-Guillermo, Armando; Tomas, Jose Francisco; Briones, Javier; Martin Garcia-Sancho, Alejandro; Sancho, Juan Manuel; Moraleda, Jose Maria; Terol, Maria Jose; Salar, Antonio; Palomera, Luis et al. DOI: 10.1080/10428194.2021.1971216 A randomized phase II study comparing consolidation with a single dose of (90)Y ibritumomab tiuxetan vs. maintenance with rituximab for two years in patients with newly diagnosed follicular lymphoma responding to R-CHOP. Long-term follow-up results. PMID: 34459702 Journal: LEUKEMIA & LYMPHOMA Year: 2022 Reference: Leuk Lymphoma. 2022 Jan;63(1):93-100. doi: 10.1080/10428194.2021.1971216. Epub 2021 Aug 30. Impact factor: Publication type: Paper in international publication Authors: Bargay, Joan; Briones, Javier; Canales, Miguel Angel; Conde, Eulogio; Deben, Guillermo; Dlouhy, Ivan; Ferrer, Secundino; Garcia Marco, Jose A; Gardella, Santiago; Hernandez, Miguel T et al. DOI: 10.1080/10428194.2021.1971216 Pagination First page « First Previous page ‹ Previous … Page 131 Page 132 Page 133 Page 134 Current page 135 Page 136 Page 137 Page 138 Page 139 … Next page Next › Last page Last »
